Research Guideline Recommendations for Research on Stem Cells, Human Embryos, and Gene Editing. [PDF]
Var SR +15 more
europepmc +1 more source
Emerging role of HIC1 in prostate cancer progression and therapeutic response: A novel perspective
HIC1 inhibits AR expression to suppress the development of castration‐resistant prostate cancer through the IRS2/PI3K/AKT axis. Abstract Prostate cancer (PCa) is a leading cause of cancer‐related death in men, with its progression and treatment response being complex. The study focuses on the role of HIC1 (Hypermethylated in cancer 1) in PCa, revealing
Dun Xue +5 more
wiley +1 more source
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCT. [PDF]
Wu YX +16 more
europepmc +1 more source
Delta opioid receptor agonists improved social avoidance, depression, and anxiety‐like symptoms induced by chronic social defeat stress within 14 days of chronic administration. Furthermore, the therapeutic effects were observed earlier than with the existing antidepressant paroxetine (28 days).
Akihisa Tokuda +8 more
wiley +1 more source
Screening for anti-Leishmania antibodies and Leishmania infections in kidney transplant recipients and donors from Brazil. [PDF]
Johanson GH +7 more
europepmc +1 more source
ABSTRACT Autophagy is a highly conserved intracellular process involved in maintaining homeostasis and in the degradation of damaged organelles and external pathogens. Nature provides complex and varied reservoirs of scaffolds and chemical entities that may have a pivotal role in the search for new therapeutic leads.
Ilaria Cursaro +5 more
wiley +1 more source
Electroacupuncture Preconditioning Ameliorates the Ischemic Microenvironment to Improve Long-Term Potentiation in Chronic Cerebral Hypoperfusion Rats With MGE Neural Progenitor Transplantation. [PDF]
Li D +6 more
europepmc +1 more source
Renal transplantation in the highly sensitized patient: The role of thoracic duct drainage, plasmapheresis, and staph A immunodepletion [PDF]
Shapiro, R, Starzl, TE
core
Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide
Objectives To evaluate the longitudinal transcriptomic changes that occurred over time in patients from the ENACT trial (ClinicalTrials.gov identifier: NCT02799745). ENACT evaluated patients with low‐ or intermediate‐risk prostate cancer, comparing the efficacy and safety of enzalutamide plus active surveillance (AS) to AS alone.
Nicole Handa +12 more
wiley +1 more source

